Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE2A | O00408 | 10/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | DAO | P14920 | 1/20 | 0.35 |
| ▸ | PDE1B | Q01064 | 1/20 | 0.35 |
| ▸ | PARP1 | P09874 | 2/20 | 0.35 |
| ▸ | CCR2 | P41597 | 1/20 | 0.34 |
| ▸ | CCR5 | P51681 | 1/20 | 0.34 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.34 |
| ▸ | PLAT | P00750 | 1/20 | 0.33 |
| ▸ | PGR | P06401 | 1/20 | 0.33 |
| ▸ | PREP | P48147 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2454917 | 0.92 | PDE2A (0.44) | PDE2APDE1BCCR2CCR5NR3C1 | |
| SCHEMBL2457418 | 0.91 | CCR2 (0.42) | PDE2APDE1BCCR2CCR5NR3C1 | |
| SCHEMBL2456944 | 0.91 | PDE2A (0.41) | PDE2APDE1BNR3C1 | |
| SCHEMBL2457053 | 0.87 | PDE2A (0.45) | PDE2ANR3C1PREP | |
| SCHEMBL2460219 | 0.86 | CCR2 (0.46) | PDE2APDE1BCCR2CCR5NR3C1 | |
| SCHEMBL2456756 | 0.86 | PDE2A (0.46) | PDE2ANR3C1 | |
| SCHEMBL2455230 | 0.85 | PDE2A (0.38) | PDE2ADAONR3C1 | |
| SCHEMBL2456663 | 0.84 | CCR2 (0.48) | PDE2APDE1BCCR2CCR5NR3C1 | |
| SCHEMBL2455160 | 0.84 | CCR2 (0.43) | PDE2ADAOPDE1BCCR2NR3C1 | |
| SCHEMBL2465875 | 0.84 | NR3C1 (0.33) | PDE2ANR3C1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011114148-A1 | 4H- [1, 2, 4] TRIAZOLO [5, 1 -B] PYRIMIDIN-7 -ONE DERIVATIVES AS CCR2B RECEPTOR ANTAGONISTS | ASTRAZENECA AB (SE) | 2011-09-22 | — | — | WO | claimed |
| WO-2011114148-A1 | 4H- [1, 2, 4] TRIAZOLO [5, 1 -B] PYRIMIDIN-7 -ONE DERIVATIVES AS CCR2B RECEPTOR ANTAGONISTS | ASTRAZENECA AB (SE) | 2011-09-22 | — | — | WO | disclosed |
| WO-2011114148-A1 | 4H- [1, 2, 4] TRIAZOLO [5, 1 -B] PYRIMIDIN-7 -ONE DERIVATIVES AS CCR2B RECEPTOR ANTAGONISTS | ASTRAZENECA AB (SE) | 2011-09-22 | — | — | WO | disclosed |